RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 79 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $116,161 | +66.1% | 5,067 | +19.4% | 0.01% | +66.7% |
| Q2 2023 | $69,951 | +74.9% | 4,242 | +22.8% | 0.00% | +200.0% |
| Q1 2022 | $40,000 | +17.6% | 3,454 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $34,000 | -24.4% | 3,454 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $45,000 | -33.8% | 3,454 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $68,000 | +7.9% | 3,454 | +16.3% | 0.00% | 0.0% |
| Q1 2021 | $63,000 | -28.4% | 2,970 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $88,000 | +37.5% | 2,970 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $64,000 | -3.0% | 2,970 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $66,000 | +73.7% | 2,970 | +18.1% | 0.00% | +50.0% |
| Q1 2020 | $38,000 | -34.5% | 2,515 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $58,000 | +34.9% | 2,515 | +26.6% | 0.00% | +50.0% |
| Q3 2019 | $43,000 | -2.3% | 1,986 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $44,000 | +57.1% | 1,986 | +95.5% | 0.00% | +100.0% |
| Q1 2019 | $28,000 | +3.7% | 1,016 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $27,000 | -10.0% | 1,016 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $30,000 | -6.2% | 1,016 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $32,000 | +128.6% | 1,016 | +45.1% | 0.00% | +100.0% |
| Q1 2018 | $14,000 | -30.0% | 700 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $20,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |